Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

robot
Abstract generation in progress

Xenon Pharmaceuticals (NASDAQ:XENE) experienced unusually high options trading activity, with traders acquiring 4,063 put options, a 2,362% increase over the average, signaling bearish sentiment. This comes despite the stock having a consensus “Buy” rating and trading higher on the reported day. The article also notes significant insider selling, including a large transaction by the CEO, alongside institutional inflows and various analyst ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)